These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30082910)

  • 1. Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1α stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment.
    Feng J; Zhang Y; She X; Sun Y; Fan L; Ren X; Fu H; Liu C; Li P; Zhao C; Liu Q; Liu Q; Li G; Wu M
    Oncogene; 2019 Jan; 38(1):103-119. PubMed ID: 30082910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer.
    Li Y; Zhang D; Wang X; Yao X; Ye C; Zhang S; Wang H; Chang C; Xia H; Wang YC; Fang J; Yan J; Ying H
    Sci Rep; 2015 Jul; 5():12495. PubMed ID: 26205124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor inhibiting HIF limits the expression of hypoxia-inducible genes in podocytes and distal tubular cells.
    Schödel J; Bohr D; Klanke B; Schley G; Schlötzer-Schrehardt U; Warnecke C; Kurtz A; Amann K; Eckardt KU; Willam C
    Kidney Int; 2010 Nov; 78(9):857-67. PubMed ID: 20720525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAT1 is a novel upstream regulator of HIF1α and invasion of high grade glioma.
    Madan E; Dikshit B; Gowda SH; Srivastava C; Sarkar C; Chattopadhyay P; Sinha S; Chosdol K
    Int J Cancer; 2016 Dec; 139(11):2570-82. PubMed ID: 27536856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme.
    Hsieh CH; Lin YJ; Wu CP; Lee HT; Shyu WC; Wang CC
    Clin Cancer Res; 2015 Jan; 21(2):460-70. PubMed ID: 25370472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.
    Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G
    Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells.
    Guo X; Xue H; Guo X; Gao X; Xu S; Yan S; Han X; Li T; Shen J; Li G
    Oncotarget; 2015 Dec; 6(39):41620-37. PubMed ID: 26536662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIH1 (factor inhibiting HIF-1) in the kidney: more than an oxygen sensor?
    Sirin Y; Pavenstädt H
    Kidney Int; 2010 Nov; 78(9):836-7. PubMed ID: 20948541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA‑566 modulates vascular endothelial growth factor by targeting Von Hippel‑Landau in human glioblastoma in vitro and in vivo.
    Xiao B; Zhou X; Ye M; Lv S; Wu M; Liao C; Han L; Kang C; Zhu X
    Mol Med Rep; 2016 Jan; 13(1):379-85. PubMed ID: 26572705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
    Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
    J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition.
    Liu N; Xia WY; Liu SS; Chen HY; Sun L; Liu MY; Li LF; Lu HM; Fu YJ; Wang P; Wu H; Gao JX
    Sci Rep; 2016 Feb; 6():20489. PubMed ID: 26841847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of glucose metabolism by p62/SQSTM1 through HIF1α.
    Chen K; Zeng J; Xiao H; Huang C; Hu J; Yao W; Yu G; Xiao W; Xu H; Ye Z
    J Cell Sci; 2016 Feb; 129(4):817-30. PubMed ID: 26743088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ankyrin Repeat Proteins of Orf Virus Influence the Cellular Hypoxia Response Pathway.
    Chen DY; Fabrizio JA; Wilkins SE; Dave KA; Gorman JJ; Gleadle JM; Fleming SB; Peet DJ; Mercer AA
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY; Poellinger L; Walker CL
    Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
    Huang S; Qi P; Zhang T; Li F; He X
    Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Zhao P; Fu Y; Yang X; Abdoulaye HA; Rauniyar R; Peng J; Wang M; Wang H; Ning M; Chen Y; Huang Y
    Transl Cancer Res; 2021 Mar; 10(3):1358-1367. PubMed ID: 35116461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats.
    Wang D; Berglund AE; Kenchappa RS; MacAulay RJ; Mulé JJ; Etame AB
    Sci Rep; 2017 Aug; 7(1):9350. PubMed ID: 28839258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.